Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 20, 2023
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
Robert Burns Maintained (ADCT) at Strong Buy with Decreased Target to $12 on, Jun 20th, 2023
Robert Burns of HC Wainwright & Co., Maintained "ADC Therapeutics SA" (ADCT) at Strong Buy with Decreased Target from $20 to $12 on, Jun 20th, 2023.
Robert has made no other calls on ADCT in the last 4 months.
There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Robert's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robert
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $10 on, Wednesday, May 10th, 2023
- Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $2 on, Monday, April 24th, 2023
